Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

2.9K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction: Interventions against disability in frail older adults: Lessons learned from clinical trials.

The journal of nutrition, health & aging·2026
Same author

Corrigendum to "Current and investigational medications for the treatment of sarcopenia" [Metabolism 2023;149:155597].

Metabolism: clinical and experimental·2026
Same author

Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2025
Same author

Editorial: ICOPE Healthy Longevity Integrative Preventive Care, Alzheimer's Disease Prevention and Early Diagnosis.

The journal of prevention of Alzheimer's disease·2024
Same author

Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2024
Same author

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Revue neurologique·2024

Related Experiment Video

Updated: Nov 2, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.5K

Identifying Biomarkers for Biological Age: Geroscience and the ICFSR Task Force.

N K LeBrasseur1, R de Cabo, R Fielding

  • 1Nathan K. LeBrasseur, Robert and Arlene Kogod Center on Aging and Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA, lebrasseur.nathan@mayo.edu.

The Journal of Frailty & Aging
|June 9, 2021
PubMed
Summary

Geroscience research aims to delay aging

Keywords:
Agingfrailtyhallmarks of agingresiliencetranslational research

More Related Videos

A Quantitative Fitness Analysis Workflow
11:39

A Quantitative Fitness Analysis Workflow

Published on: August 13, 2012

14.7K
Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

117

Related Experiment Videos

Last Updated: Nov 2, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.5K
A Quantitative Fitness Analysis Workflow
11:39

A Quantitative Fitness Analysis Workflow

Published on: August 13, 2012

14.7K
Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

117

Area of Science:

  • Geroscience
  • Aging Biology
  • Gerontology

Background:

  • The International Conference on Frailty and Sarcopenia Research Task Force convened in March 2020.
  • The meeting occurred during the COVID-19 pandemic.
  • Discussions focused on advancing geroscience, which targets aging mechanisms to maintain function and prevent frailty.

Purpose of the Study:

  • To identify and validate biomarkers for the hallmarks of aging.
  • To discuss strategies for advancing the interdisciplinary field of geroscience.
  • To address research gaps in aging and frailty.

Main Methods:

  • Task force meeting and discussion.
  • Review of potential biomarkers for aging hallmarks (mitochondrial dysfunction, proteostasis, stem cell dysfunction, nutrient sensing, genomic instability, telomere dysfunction, cellular senescence, epigenetic changes).
  • Consideration of the FRAILOMICS initiative and the U.S. National Institute on Aging Translational Gerontology Branch's work.

Main Results:

  • Identified key areas for geroscience research and clinical practice.
  • Highlighted numerous potential biomarkers for aging.
  • Acknowledged the FRAILOMICS initiative's role in omics studies.
  • Noted the U.S. National Institute on Aging's efforts in translating geroscience knowledge into therapies.

Conclusions:

  • Priorities include biomarker identification and validation for aging hallmarks.
  • There is a need for improved cellular and animal models in aging research.
  • Development of more reliable and sensitive measures for aging and frailty is crucial.